Menu
Enrolling by invitation NCT07513142

PPP Versus Corticosteroid for Thigh Muscle Injuries

Phase IV Interventional Thigh Muscle Injury Thigh Injury Musculoskeletal Musculoskeletal Injury Trauma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Corticosteroid, Platelet Poor Plasma.
Who it may be relevant to
Registry conditions: Thigh Muscle Injury, Thigh Injury, Musculoskeletal, Musculoskeletal Injury Trauma. Basic parameters: 15 years — 30 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

A Single Blind, Randomized Controlled Trial Evaluating Platelet Poor Plasma Versus Corticosteroid Injections as A Control for Thigh Muscle Injuries

Overview

The purpose of this study is to compare the number of days it takes for a sport participant to return to play between ultrasound guided intramuscular corticosteroid injections and platelet-poor plasma (PPP) injections for thigh muscle injuries.

Interventions

  • Drug Corticosteroid
    Only drug in the study
  • Biological Platelet Poor Plasma
    Only biologic in the study

Primary outcome measures

  • Return to Play [Time frame: Up to 1 year]
  • VAS Pain Scale [Time frame: Up to 1 year]
Secondary outcome measures (2)
  • Modified BAMIC [Time frame: Pre-Injection]
  • Peak Strength [Time frame: Up to 1 year post-injection]

Eligibility criteria

Inclusion criteria

  • 15-30 years of age (and)
  • Participant in a sport (and)
  • Confirmed thigh muscle injury

Exclusion criteria

  • Patient is incapable or unwilling to provide informed consent.
  • Patient is not within the age range
  • Patient does not have a thigh injury
  • Patient's thigh injury occurred more than 4 weeks prior to treatment
  • Patient's thigh injury requires surgical intervention
  • Patient has had an injection for their thigh injury within the past 30 days
  • Patient has thrombocytosis or other platelet abnormality in whole blood

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Andrews Research and Education Foundation — Gulf Breeze

Identifiers

NCT: NCT07513142 · PPP versus Corticosteroid

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗